Martin Dekker serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Martin Dekker has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 9, 2022 involved selling 7,834 shares valued at $7.3K.
Martin Dekker currently holds 17,666 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Dekker has been a net neutral trader of BLPH stock. They have purchased $0 and sold $0 worth of shares.
Martin Dekker's most recent insider trade was on Dec 9, 2022, when they sold 7,834 shares at $0.93 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 15, 2019 | BLPH | $9.2K | Payment | 27,134 | $0.34 | Discretionary |
| Sep 25, 2018 | BLPH | $0 | Award | 82,243 | $N/A | Discretionary |
| Jun 12, 2018 | BLPH | $17.7K | Payment | 7,473 | $2.37 | Discretionary |
| Jan 12, 2018 | BLPH | $0 | Award | 21,675 | $N/A | Discretionary |
| Jan 4, 2018 | BLPH | $60.5K | Payment | 24,284 | $2.49 | Discretionary |
| Mar 16, 2017 | BLPH | $0 | Award | 56,411 | $N/A | Discretionary |
| Sep 12, 2016 | BLPH | $18.4K | Payment | 13,333 | $1.38 | Discretionary |
| Jan 19, 2016 | BLPH | $0 | Award | 36,514 | $N/A | Discretionary |